Can-Fite BioPharma Ltd.CANFNYSE
Loading
Asset Growth Under PressureDecelerating
Percentile Rank59
Year-over-Year Change
Year-over-year total asset growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P59
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
3.64%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | -15.35% |
| Q4 2024 | 0.00% |
| Q3 2024 | 54.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | -40.71% |
| Q4 2023 | 8.94% |
| Q3 2023 | -16.89% |
| Q2 2023 | -18.21% |
| Q1 2023 | 45.31% |
| Q4 2022 | -26.94% |
| Q3 2022 | -13.83% |
| Q2 2022 | -17.38% |
| Q1 2022 | -11.88% |
| Q4 2021 | 38.35% |
| Q3 2021 | 51.23% |
| Q2 2021 | -24.03% |
| Q1 2021 | 33.80% |
| Q4 2020 | -28.54% |
| Q3 2020 | 4.11% |
| Q2 2020 | 29.98% |
| Q1 2020 | 20.46% |
| Q4 2019 | -30.43% |
| Q3 2019 | -14.02% |
| Q2 2019 | 82.49% |
| Q1 2019 | -5.82% |
| Q4 2018 | -26.54% |
| Q3 2018 | -1.45% |
| Q2 2018 | -11.95% |
| Q1 2018 | 59.28% |
| Q4 2017 | -10.68% |
| Q3 2017 | -14.78% |
| Q2 2017 | -16.07% |
| Q1 2017 | 20.58% |
| Q4 2016 | -13.99% |
| Q3 2016 | -14.47% |
| Q2 2016 | -15.87% |
| Q1 2016 | -6.67% |
| Q4 2015 | 15.71% |
| Q3 2015 | 77.86% |